Skip to main content
. 2020 Nov 30;11:6093. doi: 10.1038/s41467-020-19965-6

Table 2.

Adverse effects.

Parameter FLOT SOX
WBC decreased
   Grade 0, 1, 2 30 (96.8) 24 (100.0)
   Grade 3, 4 1 (3.2) 0
Neutrophil count decreased
   Grade 0, 1, 2 29 (93.5) 22 (91.7)
   Grade 3, 4 2 (6.5) 2 (8.3)
Febrile neutropenia
   Grade 0, 1, 2 31 (100.0) 23 (95.8)
   Grade 3, 4 0 1 (4.2)
Anemia
   Grade 0, 1, 2 27 (87.1) 22 (91.7)
   Grade 3, 4 4 (12.9) 2 (8.3)
Platelet count decreased
   Grade 0, 1, 2 30 (96.8) 24 (100.0)
   Grade 3, 4 1 (3.2) 0
Aminotrasferase increased
   Grade 0, 1, 2 30 (96.8) 24 (100.0)
   Grade 3, 4 1 (3.2) 0
Nausea
   Grade 0, 1, 2 30 (96.8) 24 (100.0)
   Grade 3, 4 1 (3.2) 0
Vomiting
   Grade 0, 1, 2 30 (96.8) 24 (100.0)
   Grade 3, 4 1 (3.2) 0
Diarrhea
   Grade 0, 1, 2 31 (100.0) 24 (100.0)
   Grade 3, 4 0 0
Peripheral neuropathy
   Grade 0, 1, 2 31 (100.0) 24 (100.0)
   Grade 3, 4 0 0
Fatigue
   Grade 0, 1, 2 31 (100.0) 24 (100.0)
   Grade 3, 4 0 0
Anorexia
   Grade 0, 1, 2 30 (96.8) 24 (100.0)
   Grade 3, 4 1 (3.2) 0
Oral mucositis
   Grade 0, 1, 2 31 (100.0) 24 (100.0)
   Grade 3, 4 0 0

Analysis of per-protocol population except otherwise indicated.